EVAR Stent Grafts Market Analysis and Latest Trends

EVAR (Endovascular Aneurysm Repair) stent grafts are minimally invasive devices used for the treatment of abdominal aortic aneurysms (AAA). These stent grafts are designed to be placed inside the aorta in order to effectively exclude the aneurysm from the blood circulation and prevent rupture.

The EVAR stent grafts market has witnessed significant growth in recent years. The rising prevalence of AAA, better treatment outcomes, and technological advancements in stent grafts are driving market growth. Additionally, the growing geriatric population, which is more susceptible to AAA, is further propelling market expansion.

In terms of market trends, there is a growing demand for fenestrated and branched stent grafts. These advanced devices allow for the treatment of complex aneurysms that involve branches of the aorta supplying blood to major organs. Furthermore, there is an increasing focus on the development of bioabsorbable stent grafts, which eliminates the need for long-term implantation.

Geographically, North America holds the largest share in the EVAR stent grafts market, primarily driven by the high prevalence of AAA and the adoption of advanced healthcare technologies. However, the Asia-Pacific region is expected to experience rapid growth due to the rising geriatric population, improving healthcare infrastructure, and increasing awareness about the benefits of endovascular procedures.

Overall, the EVAR stent grafts market is projected to grow at a CAGR of 5.4% during the forecast period. Factors such as the increasing prevalence of AAA, technological advancements, and growing geriatric population are expected to drive market growth. Additionally, the demand for advanced fenestrated and branched stent grafts and the development of bioabsorbable devices are key trends shaping the market.

Get a Sample PDF of the Report: https://www.reliableresearchreports.com/enquiry/request-sample/933242

EVAR Stent Grafts Major Market Players

The global EVAR (Endovascular Aneurysm Repair) Stent Grafts market is highly competitive, with several key players dominating the industry. Some of the major players in the market include Medtronic, Terumo (Vascutek), Cordis (a division of Cardinal Health), Boston Scientific, Endologix, TriVascular, and MicroPort Scientific.

Medtronic is a leading company in the EVAR Stent Grafts market, offering a wide range of products for the treatment of aortic aneurysms. The company's market growth has been fueled by its strong product portfolio and extensive distribution network. Medtronic continues to expand its market presence through acquisitions and technological advancements. Its future growth is expected to be driven by the increasing prevalence of aortic aneurysms and the growing adoption of minimally invasive procedures.

Terumo (Vascutek) is another prominent player in the market, known for its innovative stent graft solutions. The company has experienced steady market growth, primarily attributed to its focus on product development and strategic partnerships. Terumo's future growth prospects are promising, as it continues to invest in R&D and expand its global market presence.

Cordis, a division of Cardinal Health, is a well-established player in the EVAR Stent Grafts market. The company offers a range of stent graft systems, and its market growth is driven by its strong brand reputation and extensive customer base. Cordis is expected to maintain steady growth in the future, supported by its focus on product innovation and geographical expansion.

Boston Scientific is also a key player in the market, offering a comprehensive portfolio of EVAR Stent Grafts. The company's market growth is attributed to its strong marketing strategy and focus on customer satisfaction. Boston Scientific is expected to witness significant future growth, driven by its efforts to introduce technologically advanced products and expand its global footprint.

Specific sales revenue numbers for these companies are not readily available. However, it is worth mentioning that the global EVAR Stent Grafts market was valued at around $1.5 billion in 2020, and it is expected to reach over $2.2 billion by 2027. This indicates the overall market growth potential and the opportunities for market players to increase their sales revenue.

In conclusion, the EVAR Stent Grafts market is highly competitive, with major players like Medtronic, Terumo (Vascutek), Cordis (a division of Cardinal Health), Boston Scientific, Endologix, TriVascular, and MicroPort Scientific leading the industry. These companies have witnessed significant market growth and are expected to continue expanding their market share in the future, driven by product innovation and strategic partnerships. The global EVAR Stent Grafts market is projected to grow rapidly, creating ample opportunities for sales revenue growth for these market players.

What Are The Key Opportunities For EVAR Stent Grafts Manufacturers?

The EVAR (Endovascular Aneurysm Repair) Stent Grafts market is experiencing significant growth due to the rising prevalence of aortic aneurysms and increasing adoption of minimally invasive procedures. The market is driven by advancements in stent graft technology, such as improved flexibility, better sealing, and reduced complications. Additionally, favorable reimbursement policies and rising healthcare expenditure are further propelling market growth. The future outlook for the EVAR Stent Grafts market looks promising, with increasing research and development activities for innovative products. The market is expected to witness continued growth, driven by the aging population and a growing preference for minimally invasive procedures.

Inquire or Share Your Questions If Any Before Purchasing This Report:https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/933242

Market Segmentation

The EVAR Stent Grafts Market Analysis by types is segmented into: